Carbamazepine Tablets USP, 200 mg have an estimated market size of US$ 32 million for twelve months ending December 2024 according to IQVIA
The approved product, Mesalamine Suppositories 1000 mg, has an estimated U.S. market size of US$ 29 million
The discontinuation decision is only on the basis of commercial reasons and is not due to efficacy or safety reasons
More than 40 types of Amyloid proteins are discovered till date
David joins HCTI with a distinguished career of over 22 years of corporate finance experience
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
The product will be launched in Q1FY26
The company does not expect this development to have any material impact on the current business operations
The Atlan A100 system delivers advanced ventilation technology for adults, pediatric patients, and neonates, revolutionizing care with seamless workflows across hospital departments
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
